Cargando…

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia

BACKGROUND: Numerous studies have demonstrated that patients with Parkinson's disease (PD) have a higher prevalence of substantia nigra (SN) hyperechogenicity compared with controls. Our aim was to explore the neuroimaging characteristics of transcranial sonography (TCS) of patients with PD and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Zhi-Fen, Wang, Cai-Shan, Zhang, Ying-Chun, Zhang, Ying, Sheng, Yu-Jing, Hu, Hua, Luo, Wei-Feng, Liu, Chun-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634077/ https://www.ncbi.nlm.nih.gov/pubmed/28937033 http://dx.doi.org/10.4103/0366-6999.215329

Ejemplares similares

Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson’s disease
por: Li, Kai, et al.
Publicado: (2020)

Substantia nigra hyperechogenicity in Parkinson disease patients with leucine-rich repeat kinase 2 variants in the Chinese Han population
por: Li, Kai, et al.
Publicado: (2020)

Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis
por: Mei, Yan-Liang, et al.
Publicado: (2021)

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
por: Reeve, Amy K., et al.
Publicado: (2018)

Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis
por: Li, Dun-Hui, et al.
Publicado: (2016)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
por: Wang, Lu, et al.
Publicado: (2021)

Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients
por: Bouwmans, Angela E P, et al.
Publicado: (2013)

Altered functional connectivity of the red nucleus and substantia nigra in migraine without aura
por: Huang, Xiaobin, et al.
Publicado: (2019)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
por: Liu, Wenyue, et al.
Publicado: (2021)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
por: Zhou, Hai-Yan, et al.
Publicado: (2018)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson's Disease
por: Romeo, Stefania, et al.
Publicado: (2014)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease
por: Schneider, Jay S.
Publicado: (2018)

Distinct alterations in cerebellar connectivity with substantia nigra and ventral tegmental area in Parkinson’s disease
por: O’Shea, Ian M., et al.
Publicado: (2022)

Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study
por: Bouwmans, Angela E. P., et al.
Publicado: (2016)

Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra
por: Huang, Chun, et al.
Publicado: (2017)

Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson’s disease: a pilot study from China
por: Chen, Wei, et al.
Publicado: (2012)

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang
por: Wei, Rurui, et al.
Publicado: (2023)

Preliminary Study of ADHD Biomarkers in Adults with Focus on Serum Iron and Transcranial Sonography of the Substantia Nigra
por: Bahn, Geon-Ho, et al.
Publicado: (2021)

Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease
por: Huang, Maoxin, et al.
Publicado: (2022)

Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease
por: Cao, Qing, et al.
Publicado: (2023)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model
por: Lu, Yi, et al.
Publicado: (2018)

Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease
por: Zang, Zhenxiang, et al.
Publicado: (2022)

The history of the research of iron in parkinsonian substantia nigra
por: Friedman, Andrzej, et al.
Publicado: (2012)

Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pl9424hbtt51cd04538dk2aern